BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32176488)

  • 1. Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase Inhibitors.
    Di Martino S; Tardia P; Cilibrasi V; Caputo S; Mazzonna M; Russo D; Penna I; Realini N; Margaroli N; Migliore M; Pizzirani D; Ottonello G; Bertozzi SM; Armirotti A; Nguyen D; Sun Y; Bongarzone ER; Lansbury P; Liu M; Skerlj R; Scarpelli R
    J Med Chem; 2020 Apr; 63(7):3634-3664. PubMed ID: 32176488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzoxazolone Carboxamides as Potent Acid Ceramidase Inhibitors: Synthesis and Structure-Activity Relationship (SAR) Studies.
    Bach A; Pizzirani D; Realini N; Vozella V; Russo D; Penna I; Melzig L; Scarpelli R; Piomelli D
    J Med Chem; 2015 Dec; 58(23):9258-72. PubMed ID: 26560855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A HILIC-MS/MS method for simultaneous quantification of the lysosomal disease markers galactosylsphingosine and glucosylsphingosine in mouse serum.
    Sidhu R; Mikulka CR; Fujiwara H; Sands MS; Schaffer JE; Ory DS; Jiang X
    Biomed Chromatogr; 2018 Jul; 32(7):e4235. PubMed ID: 29516569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors.
    Caputo S; Di Martino S; Cilibrasi V; Tardia P; Mazzonna M; Russo D; Penna I; Summa M; Bertozzi SM; Realini N; Margaroli N; Migliore M; Ottonello G; Liu M; Lansbury P; Armirotti A; Bertorelli R; Ray SS; Skerlj R; Scarpelli R
    J Med Chem; 2020 Dec; 63(24):15821-15851. PubMed ID: 33290061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphingolipids by N-acetylation with [3H]acetic anhydride.
    Bodennec J; Trajkovic-Bodennec S; Futerman AH
    J Lipid Res; 2003 Jul; 44(7):1413-9. PubMed ID: 12730305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosphingolipids and sphingolipidoses: Psychosine in Krabbe's disease.
    Spassieva S; Bieberich E
    J Neurosci Res; 2016 Nov; 94(11):974-81. PubMed ID: 27638582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease.
    Kobayashi T; Shinoda H; Goto I; Yamanaka T; Suzuki Y
    Biochem Biophys Res Commun; 1987 Apr; 144(1):41-6. PubMed ID: 3579916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive accumulation of toxic metabolite in a genetic leukodystrophy.
    Igisu H; Suzuki K
    Science; 1984 May; 224(4650):753-5. PubMed ID: 6719111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease.
    Khan M; Haq E; Giri S; Singh I; Singh AK
    J Neurosci Res; 2005 Jun; 80(6):845-54. PubMed ID: 15898099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of pathogenesis in twitcher mouse, an enzymatically authentic model of Krabbe's disease.
    Inui K; Nishimoto J; Taniike M; Midorikawa M; Tsukamoto H; Okada S; Yabuuchi H
    J Neurol Sci; 1990 Dec; 100(1-2):124-30. PubMed ID: 2128519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective extraction and effective separation of galactosylsphingosine (psychosine) and glucosylsphingosine from other glycosphingolipids in pathological tissue samples.
    Li YT; Li SC; Buck WR; Haskins ME; Wu SW; Khoo KH; Sidransky E; Bunnell BA
    Neurochem Res; 2011 Sep; 36(9):1612-22. PubMed ID: 21136152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipid profile in the CNS of the twitcher (globoid cell leukodystrophy) mouse: a lipidomics approach.
    Esch SW; Williams TD; Biswas S; Chakrabarty A; LeVine SM
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):779-87. PubMed ID: 14528915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical pathogenesis of genetic leukodystrophies: comparison of metachromatic leukodystrophy and globoid cell leukodystrophy (Krabbe's disease).
    Suzuki K
    Neuropediatrics; 1984 Sep; 15 Suppl():32-6. PubMed ID: 6152811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death.
    Giri S; Khan M; Rattan R; Singh I; Singh AK
    J Lipid Res; 2006 Jul; 47(7):1478-92. PubMed ID: 16645197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies.
    Abdelkarim H; Marshall MS; Scesa G; Smith RA; Rue E; Marshall J; Elackattu V; Stoskute M; Issa Y; Santos M; Nguyen D; Hauck Z; van Breemen R; Celej MS; Gaponenko V; Bongarzone ER
    Sci Rep; 2018 Aug; 8(1):12462. PubMed ID: 30127535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzoxazolone carboxamides: potent and systemically active inhibitors of intracellular acid ceramidase.
    Pizzirani D; Bach A; Realini N; Armirotti A; Mengatto L; Bauer I; Girotto S; Pagliuca C; De Vivo M; Summa M; Ribeiro A; Piomelli D
    Angew Chem Int Ed Engl; 2015 Jan; 54(2):485-9. PubMed ID: 25395373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation.
    Hoogerbrugge PM; Suzuki K; Suzuki K; Poorthuis BJ; Kobayashi T; Wagemaker G; van Bekkum DW
    Science; 1988 Feb; 239(4843):1035-8. PubMed ID: 3278379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of galactosylsphingosine (psychosine) in the twitcher mouse.
    Mitsuo K; Kobayashi T; Shinnoh N; Goto I
    Neurochem Res; 1989 Sep; 14(9):899-903. PubMed ID: 2512514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosine enhances the shedding of membrane microvesicles: Implications in demyelination in Krabbe's disease.
    D'Auria L; Reiter C; Ward E; Moyano AL; Marshall MS; Nguyen D; Scesa G; Hauck Z; van Breemen R; Givogri MI; Bongarzone ER
    PLoS One; 2017; 12(5):e0178103. PubMed ID: 28531236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease.
    Cabrera-Salazar MA; Deriso M; Bercury SD; Li L; Lydon JT; Weber W; Pande N; Cromwell MA; Copeland D; Leonard J; Cheng SH; Scheule RK
    PLoS One; 2012; 7(8):e43310. PubMed ID: 22912851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.